Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
Depending on the exchange, the stock ticker may vary. For instance, on Grey Market exchange Bioretec Oy stocks are traded under the ticker BRTCF.
When is the next Bioretec Oy earnings date?▼
Bioretec Oy is going to release the next earnings report on February 12, 2027.
What were Bioretec Oy earnings last quarter?▼
BRTCF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0.01 USD resulting in a -129.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bioretec Oy revenue for the last year?▼
Bioretec Oy revenue for the last year amounts to 4.14M USD.
What is Bioretec Oy net income for the last year?▼
BRTCF net income for the last year is -11.15M USD.